magnoflorine, magnoflorine iodide, (S)-isomer, magnoflorine perchlorate, (S)-isomer
Name | Magnoflorine | ||
PubChem CID | 73337 | ||
Molecular Weight | 342.4g/mol | ||
Synonyms |
magnoflorine, magnoflorine iodide, (S)-isomer, magnoflorine perchlorate, (S)-isomer |
||
Formula | C₂₀H₂₄NO₄+ | ||
SMILES | C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C | ||
InChI | 1S/C20H23NO4/c1-21(2)8-7-12-10-15(25-4)20(23)18-16(12)13(21)9-11-5-6-14(24-3)19(22)17(11)18/h5-6,10,13H,7-9H2,1-4H3,(H-,22,23)/p+1/t13-/m0/s1 | ||
InChIKey | YLRXAIKMLINXQY-ZDUSSCGKSA-O | ||
CAS Number | 2141-09-5 | ||
ChEMBL ID | CHEMBL235428 | ||
ChEBI ID | CHEBI:6641 | ||
Herb ID | HBIN034216 | ||
KEGG ID | C09581 | ||
Toxicity | Organism | Test Type | Route(Dose) |
rat | LD50 | intraperitoneal(165 mg/kg) | |
mouse | LD50 | intraperitoneal(254 mg/kg) | |
rat | LD50 | oral(322 mg/kg) | |
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | HuangLian | ||
Use Part | Rhizome | ||
Habitat | SiChuan, YunNan, HuBei | ||
Flavor | Bitter | ||
Meridian Tropism | Heart; Spleen; Stomach; Liver; Gallbladder; Large Intestine | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Ranunculales
-->Family: Ranunculaceae
-->Genus: Coptis
-->Species: Coptis chinensis
|
Pair Name | Magnoflorine, Docetaxel | |||
Partner Name | Docetaxel | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
In Vitro Model | 23132/87 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_1046 |
AGS | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0139 | |
MKN74 | Gastric tubular adenocarcinoma | Homo sapiens (Human) | CVCL_2791 | |
NCI-N87 | Gastric tubular adenocarcinoma | Homo sapiens (Human) | CVCL_1603 | |
In Vivo Model | Zebrafish embryos of the AB strain were studied under standard conditions (28.5 °C, 14 h light/10 h dark cycle) in an incubator. | |||
Result | Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel |
Pair Name | Magnoflorine, Doxorubicin | |||
Partner Name | Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | BECN1 | hsa8678 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Up-regulation | Expression | MAP1LC3B | hsa81631 | |
Up-regulation | Phosphorylation | MAPK14 | hsa1432 | |
Down-regulation | Phosphorylation | MTOR | hsa2475 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
Down-regulation | Expression | SQSTM1 | hsa8878 | |
Up-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
In Vivo Model | 1×10⁷ MCF-7 cells suspended in 0.2 ml PBS were injected into the right flank of each mouse at a single site. | |||
Result | Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways |
No. | Title | Href |
---|---|---|
1 | Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. Biomed Pharmacother. 2020 Jan;121:109139. doi: 10.1016/j.biopha.2019.109139. | Click |
2 | Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel. Int J Mol Sci. 2023 Oct 24;24(21):15511. doi: 10.3390/ijms242115511. | Click |